Interim Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 122,136	$ 98,564
Trade accounts receivable, less allowances	611,399	647,335
Inventories	451,320	414,543
Other current assets and prepaid expenses	131,047	108,916
Total current assets	1,315,902	1,269,358
Property, plant and equipment, net	728,602	799,365
Goodwill	636,089	648,622
Other intangible assets, net	297,435	307,450
Deferred tax assets, net	34,986	39,496
Other non-current assets	281,446	262,507
Total assets	3,294,460	3,326,798
Current liabilities:
Trade accounts payable	226,681	272,911
Accrued and other liabilities	202,039	208,811
Accrued compensation and related items	184,773	236,265
Deferred Revenue	198,179	192,648
Taxes payable	199,626	134,769
Short-term borrowings and current maturities of long-term debt	153,639	101,134
Total current liabilities	1,164,937	1,146,538
Long-term debt	1,825,253	1,580,808
Deferred tax liabilities, net	76,532	62,230
Other non-current liabilities	310,547	365,801
Total liabilities	3,377,269	3,155,377
Commitments and contingencies (Note 15)
Shareholders' equity:
Preferred stock, $0.01 par value per share; authorized 10,000,000 shares	0	0
Common stock, $0.01 par value per share; authorized 125,000,000 shares; issued 44,786,011 and 44,786,011 shares; outstanding 23,794,563 and 24,125,317 shares at September 30, 2020 and December 31, 2019, respectively	448	448
Additional paid-in capital	842,421	825,974
Treasury stock at cost (20,991,448 shares at September 30, 2020 and 20,660,694 shares at December 31, 2019)	(7,064,513)	(6,259,049)
Retained earnings	6,463,349	5,859,272
Accumulated other comprehensive loss	(324,514)	(255,224)
Total shareholders' equity	(82,809)	171,421
Total liabilities and shareholders' equity	$ 3,294,460	$ 3,326,798